Weighing the benefits and risks of aspirin for primary prevention of vascular disease.
M K
MK
Garg
D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D011322:Primary Prevention
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin